TELA Bio (NASDAQ:TELA) Cut to “Neutral” at Piper Sandler

Piper Sandler lowered shares of TELA Bio (NASDAQ:TELA – Free Report) from an overweight rating to a neutral rating in a research report sent to investors on Friday, Marketbeat Ratings reports. The brokerage currently has $2.00 target price on the stock, down from their previous target price of $5.00. TELA Bio Stock Performance NASDAQ:TELA opened […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Set Exelixis, Inc. (NASDAQ:EXEL) Price Target at $37.59
Next post Franklin Covey’s (FC) “Outperform” Rating Reiterated at Barrington Research